Literature DB >> 20609861

Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome.

Yoko Kano1, Tadashi Ishida, Kazuhisa Hirahara, Tetsuo Shiohara.   

Abstract

Drug-induced hypersensitivity syndrome (DIHS) is a severe systemic reaction with several herpesvirus reactivations. Multiple organ failures appear during the course of the disease. The severity of DIHS is determined by the degree of visceral involvement. Autoimmune diseases also develop several months to years after the apparent clinical resolution of DIHS. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20609861     DOI: 10.1016/j.mcna.2010.03.004

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  22 in total

Review 1.  Drug reactions with eosinophilia and systemic symptoms.

Authors:  B Scrace; A Fityan; C Bigham
Journal:  BJA Educ       Date:  2020-01-08

Review 2.  [Triggers of exanthematous drug eruptions: Stop intake, treat through or desensitization?]

Authors:  M Absmaier; T Biedermann; K Brockow
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

3.  DRESS syndrome presenting after initiation of mycobacterium avium complex osteomyelitis treatment.

Authors:  Paul W Blair; Douglas Herrin; Nawaf Abaalkhail; Wesley Fiser
Journal:  BMJ Case Rep       Date:  2015-10-05

Review 4.  [Severe cutaneous drug reactions in children].

Authors:  M Mockenhaupt
Journal:  Hautarzt       Date:  2017-10       Impact factor: 0.751

5.  A fatal presentation of DRESS syndrome with multiple visceral failure mimicking septic shock.

Authors:  Mohammed Amine Lafkih; Hamza Mimouni; Mohammed Azizi; El Kaouini Abderrahim; Mohammed Maarad; Bkiyar Houssam; Brahim Housni
Journal:  Ann Med Surg (Lond)       Date:  2022-06-28

Review 6.  Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.

Authors:  Hannah Stirton; Neil H Shear; Roni P Dodiuk-Gad
Journal:  Biomedicines       Date:  2022-04-26

Review 7.  Eosinophilic Drug Allergy.

Authors:  Merin Kuruvilla; David A Khan
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 10.817

Review 8.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.

Authors:  Yung-Tsu Cho; Che-Wen Yang; Chia-Yu Chu
Journal:  Int J Mol Sci       Date:  2017-06-09       Impact factor: 5.923

9.  Emergent high fatality lung disease in systemic juvenile arthritis.

Authors:  Gail H Deutsch; R Paul Guillerman; Johannes Birgmeier; Karthik Jagadeesh; Scott Canna; Grant Schulert; Vivian E Saper; Guangbo Chen; Robin Deterding; Jianpeng Xu; Ann N Leung; Layla Bouzoubaa; Khalid Abulaban; Kevin Baszis; Edward M Behrens; James Birmingham; Alicia Casey; Michal Cidon; Randy Q Cron; Aliva De; Fabrizio De Benedetti; Ian Ferguson; Martha P Fishman; Steven I Goodman; T Brent Graham; Alexei A Grom; Kathleen Haines; Melissa Hazen; Lauren A Henderson; Assunta Ho; Maria Ibarra; Christi J Inman; Rita Jerath; Khulood Khawaja; Daniel J Kingsbury; Marisa Klein-Gitelman; Khanh Lai; Sivia Lapidus; Clara Lin; Jenny Lin; Deborah R Liptzin; Diana Milojevic; Joy Mombourquette; Karen Onel; Seza Ozen; Maria Perez; Kathryn Phillippi; Sampath Prahalad; Suhas Radhakrishna; Adam Reinhardt; Mona Riskalla; Natalie Rosenwasser; Johannes Roth; Rayfel Schneider; Dieneke Schonenberg-Meinema; Susan Shenoi; Judith A Smith; Hafize Emine Sönmez; Matthew L Stoll; Christopher Towe; Sara O Vargas; Richard K Vehe; Lisa R Young; Jacqueline Yang; Tushar Desai; Raymond Balise; Ying Lu; Lu Tian; Gill Bejerano; Mark M Davis; Purvesh Khatri; Elizabeth D Mellins
Journal:  Ann Rheum Dis       Date:  2019-09-27       Impact factor: 19.103

Review 10.  Current Perspectives on Severe Drug Eruption.

Authors:  Jingzhan Zhang; Zixian Lei; Chen Xu; Juan Zhao; Xiaojing Kang
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-17       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.